249 related articles for article (PubMed ID: 30830300)
1. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer.
Chargi N; Bril SI; Emmelot-Vonk MH; de Bree R
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1475-1486. PubMed ID: 30830300
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia results in poor survival rates in oral cavity cancer patients.
Lin SC; Lin YS; Kang BH; Yin CH; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; She YY; Liu YH; Lee CC
Clin Otolaryngol; 2020 May; 45(3):327-333. PubMed ID: 31769607
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
4. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle.
Galli A; Colombo M; Carrara G; Lira Luce F; Paesano PL; Giordano L; Bondi S; Tulli M; Mirabile A; De Cobelli F; Bussi M
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3489-3502. PubMed ID: 32535862
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
Chargi N; Bril SI; Swartz JE; Wegner I; Willems SM; de Bree R
Oral Oncol; 2020 Feb; 101():104519. PubMed ID: 31855705
[TBL] [Abstract][Full Text] [Related]
8. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
[TBL] [Abstract][Full Text] [Related]
9. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
Fattouh M; Chang GY; Ow TJ; Shifteh K; Rosenblatt G; Patel VM; Smith RV; Prystowsky MB; Schlecht NF
Head Neck; 2019 Mar; 41(3):707-714. PubMed ID: 30582237
[TBL] [Abstract][Full Text] [Related]
10. The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy.
Huiskamp LFJ; Chargi N; Devriese LA; de Jong PA; de Bree R
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2847-2858. PubMed ID: 32335709
[TBL] [Abstract][Full Text] [Related]
11. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Ahern E; Brown TE; Campbell L; Hughes BGM; Banks M; Lin CY; Kenny LM; Bauer J
Br J Nutr; 2023 Feb; 129(3):406-415. PubMed ID: 35152926
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.
Findlay M; White K; Lai M; Luo D; Bauer JD
J Acad Nutr Diet; 2020 Aug; 120(8):1330-1347.e8. PubMed ID: 32711854
[TBL] [Abstract][Full Text] [Related]
14. The impact of skeletal muscle depletion on older adult patients with head and neck cancer undergoing primary surgery.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
J Geriatr Oncol; 2021 Jan; 12(1):128-133. PubMed ID: 32565144
[TBL] [Abstract][Full Text] [Related]
15. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
[TBL] [Abstract][Full Text] [Related]
16. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
[TBL] [Abstract][Full Text] [Related]
17. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
Nagpal P; Pruthi DS; Pandey M; Yadav A; Singh H
Oral Oncol; 2021 Oct; 121():105483. PubMed ID: 34403887
[TBL] [Abstract][Full Text] [Related]
18. Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer.
Matsuo Y; Mitsuyoshi T; Shintani T; Iizuka Y; Mizowaki T
J Geriatr Oncol; 2018 Nov; 9(6):589-593. PubMed ID: 29779799
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia and its impact in head and neck cancer treatment.
de Bree R; van Beers MA; Schaeffers AWMA
Curr Opin Otolaryngol Head Neck Surg; 2022 Apr; 30(2):87-93. PubMed ID: 35255045
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer.
Ye Z; Saraf A; Ravipati Y; Hoebers F; Catalano PJ; Zha Y; Zapaishchykova A; Likitlersuang J; Guthier C; Tishler RB; Schoenfeld JD; Margalit DN; Haddad RI; Mak RH; Naser M; Wahid KA; Sahlsten J; Jaskari J; Kaski K; Mäkitie AA; Fuller CD; Aerts HJWL; Kann BH
JAMA Netw Open; 2023 Aug; 6(8):e2328280. PubMed ID: 37561460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
